Week in Review: Patients at the center | Collaboration for kidney tumor treatment | Big Siemens ultrasound news

Dear AuntMinnie Europe member,

While advances in imaging technology and breast cancer research are improving diagnostics, patients must remain at the center of every diagnostic decision, according to an event held by the European Society of Radiology this week. 

Meanwhile, success in kidney tumor treatment can benefit from collaboration between radiologists, urologists, and patients, according to a session at JFR 2026. 

In big industry news, Siemens Healthineers announced that it would be exiting the general imaging ultrasound business to focus on procedural imaging and image-guided therapy. Click here for all of the details.

In partner content, we have a profile on breast cancer screening efforts at Maastricht UMC+. And Bayer’s Dr. Joana Reis discussed personalized breast imaging and more in a video interview.

We also have a video interview for you from neuroRAD 2026. Dr. Joe Lennerz of Natera shared his thoughts on integrated diagnostics, clinical AI, and the challenges of translating innovation into routine practice.

Meanwhile, the autumn congress season continues this weekend with the annual meeting of the European Association of Nuclear Medicine (EANM) in Vienna. Associate Editor Claudia Tschabuschnig will be on hand at Austria Center Vienna and we invite you to check back in next week for her reports.

Please see below for our full list of top stories of the week.

Erik L. Ridley
Editor in Chief
AuntMinnieEurope.com

1.     Breast cancer imaging: Patients must remain at the center

2.     JFR: Radiologists, urologists, and patients collaborate for kidney tumor treatment

3.     Siemens focuses ultrasound business on procedural imaging

4.     Behind the scan: From warehouse to patient in Maastricht

5.     neuroRAD video: Joe Lennerz on continuous evidence tracking in medical AI

6.     AI on par with radiologists for finding prostate cancer on MRI

7.     Bayer’s Joana Reis: Breast screening moves beyond one-size-fits-all

8.     Lu-177 PNT2002 before SBRT extends disease control in prostate cancer

9.     GEHC’s MINItrace Magni cyclotron gets CE Mark

10.  Aston University gets funding for pediatric brain MRI tumor research

Page 1 of 10
Next Page